Zehetner J, Holzinger F, Breuhahn Th, Geppert C, Klaiber C
Department of Surgery, Aarberg Hospital, Aarberg, Switzerland.
Surg Endosc. 2006 Feb;20(2):220-5. doi: 10.1007/s00464-005-0051-7. Epub 2006 Jan 2.
Most surgeons operate on gastroesophageal reflux disease (GERD) patients using the concept of "tailored approach," which depends on esophageal motility. We have abandoned this concept and performed laparoscopic Toupet fundoplication in all patients suffering from GERD, independent of their esophageal motility.
In a prospective trial we have assessed and evaluated our 5-year results of the first 100 consecutive patients treated with laparoscopic Toupet fundoplication. All patients were evaluated preoperatively by endoscopy and 24-h pH manometry. The patients were followed up clinically 1, 2, 6, 12 and 60 months postoperatively. The course of clinical DeMeester score, appearance and treatment of wrap-related side-effects as well as long-term outcome and patient satisfaction were evaluated.
The 5-year follow-up rate was 87%. Laparoscopic Toupet fundoplication achieved a 5-year healing rate of GERD in 85%. Of all operated patients, 3.5% had to be reinstalled on a regular PPI treatment because of postoperative GERD reappearance. The median clinical DeMeester score decreased from 4.27 +/- 1.5 points preoperatively to 0.47 +/- 0.9 points 5 years postoperatively (p < 0.0005). Because of persistent postoperative dysphagia, 5% of the patients required endoscopic dilatation therapy. Persistent postoperative gas-bloat syndrome occurred in 1.1%. Wrap dislocation was identified in 3.4% of patients. Reoperation rate was 5%. Total morbidity rate was 19.5% and operative related mortality rate was 0%. Overall, 96.6% of patients were pleased with their outcome at late follow-up, and 95.4% of patients stated they would consider undergoing laparoscopic fundoplication again if necessary.
Our long-term results showing a low recurrence and morbidity rate of laparoscopic Toupet fundoplication encourage us to continue to perform this procedure as the primary surgical repair in all GERD patients, independent of their esophageal motility. Laparoscopic Toupet fundoplication has proven to be a safe and successful therapeutic option in GERD patients.
大多数外科医生采用“个体化治疗方案”为胃食管反流病(GERD)患者进行手术,该方案取决于食管动力。我们摒弃了这一理念,对所有GERD患者均实施腹腔镜图佩特胃底折叠术,而不考虑其食管动力情况。
在一项前瞻性试验中,我们评估并分析了连续100例接受腹腔镜图佩特胃底折叠术患者的5年治疗结果。所有患者术前均接受内镜检查和24小时pH值监测。术后1、2、6、12和60个月对患者进行临床随访。评估临床DeMeester评分的变化过程、胃底折叠相关副作用的表现及处理情况、长期疗效以及患者满意度。
5年随访率为87%。腹腔镜图佩特胃底折叠术使GERD的5年治愈率达到85%。在所有接受手术的患者中,3.5%因术后GERD复发而不得不重新接受常规质子泵抑制剂治疗。临床DeMeester评分中位数从术前的4.27±1.5分降至术后5年的0.47±0.9分(p<0.0005)。因术后持续吞咽困难,5%的患者需要接受内镜扩张治疗。术后持续性气胀综合征发生率为1.1%。3.4%的患者发现胃底折叠移位。再次手术率为5%。总发病率为19.5%,手术相关死亡率为0%。总体而言,96.6%的患者对后期随访结果满意,95.4%的患者表示如有必要会考虑再次接受腹腔镜胃底折叠术。
我们的长期结果显示腹腔镜图佩特胃底折叠术的复发率和发病率较低,这促使我们继续将该手术作为所有GERD患者的主要手术修复方式,而不考虑其食管动力情况。腹腔镜图佩特胃底折叠术已被证明是GERD患者一种安全且成功的治疗选择。